Kirtane, Ajay J <br/><br/>
Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.  [electronic resource] 

 -  Circulation. Cardiovascular quality and outcomes  06 2020 
 - e006885 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1941-7705 
<br/><br/><label>Standard No.: </label>10.1161/CIRCOUTCOMES.120.006885  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Betacoronavirus<br/>COVID-19<br/>Coronavirus Infections--epidemiology<br/>Humans<br/>Pandemics<br/>Percutaneous Coronary Intervention<br/>Pneumonia, Viral--epidemiology<br/>SARS-CoV-2<br/>ST Elevation Myocardial Infarction--drug therapy<br/>Thrombolytic Therapy